Biotech

All Articles

Tracon wane weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually made a decision to unwind procedures full weeks after an inject...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on stopped working epilepsy medication, proclaims FDA operate

.Our experts presently recognize that Takeda is actually planning to find a pathway to the FDA for e...

VBI Injections apply for insolvency, looks for resource sale

.Immunology biotech VBI Vaccines is diverting alarmingly near to the defining moment, along with str...

Celldex anti-cKIT antibody lessen hives in an additional stage 2 research study

.It's not easy to muscle mass in on a space as affordable as immunology, yet Celldex Rehabs strongly...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies and also a preclinical immune...

Ventyx's last hope for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's disease medicine did not aid people obtain remission in a period 2 test...

Cognition's phase 2 beam data taint Alzheimer's prospect

.Knowledge Therapies' phase 2 sparkle trial has actually taken some of the gloss off the Alzheimer's...

BMS centers bispecific months after submitting to operate phase 3 test

.Bristol Myers Squibb has possessed a whiplash change of heart on its own BCMA bispecific T-cell eng...

Charles Baum takes over Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who oversaw Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers Squib...